Author:
de la Fouchardiere Christelle,Oussaid Nadia,Derbel Olfa,Decaussin-Petrucci Myriam,Fondrevelle Marie-Eve,Wang Qing,Bringuier Pierre-Paul,Bournaud-Salinas Claire,Peix Jean-Louis,Lifante Jean-Christophe,Giraudet Anne-Laure,Lopez Jonathan,Borson-Chazot Françoise
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Oncology
Reference33 articles.
1. DeLellis R, Lloyd RV, Heitz PU, Eng C (eds). World Health Organization Classification of Tumours. Pathology and genetics of tumours and endocrine organs. Lyon: IARC Press; 2004.
2. Gomez SL, Noone AM, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, et al. Cancer incidence trends among Asian American populations in the United States, 1990 to 2008. J Natl Cancer Inst 2013;105(15):1096-110.
3. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214
4. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP et al (2006) Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892–2899
5. Schlumberger M, Brose M, Elisei R, Leboulleux S, Luster M, Pitoia F et al (2014) Definition and management of radioactive iodine-refractory differentiated thyroid cancer. Lancet Diab Endocrinol 2:356–358
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献